Influenza Vaccine Industry Analysis, Growth, Competitive Landscape and US Forecasts to 2022 adds "United States Influenza Vaccine Market, Vaccination Analysis, Distribution, Production, Pipeline Insights, Clinical Trials, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022" report to its research store.

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

Complete report available at

Major and Promising Vaccine Covered in the US Influenza Vaccine Market Report: Fluzone High–Dose, Fluzone Quadrivalent, Intradermal (ID) Trivalent, Vaxigrip, Fluarix Quadrivalent, Flulaval Quadrivalent, Fluenz Tetra, FluMist Quadrivalent, Flublok, VN–100, M–001, VAX–2012Q, TAK – 850, Flucelvax Quadrivalent, Afluria Quadrivalent, Agrippal, Fluad, Fluvirin, Fluvax

Company Coverage: Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZenecca, Protein Sciences Corporation, Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, VaxInnate

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

Order a copy of this “United States Influenza Vaccine Market” research report at

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Key Topics Covered:
1. Executive Summary
2. United States Influenza Vaccine Market & Forecast
3. United States Number of Persons Vaccinated with Influenza Vaccine
4. United States Influenza Vaccine Market Drivers and Barriers
5. United States Influenza Vaccine Production & Distribution
6. United States Influenza Vaccine Market – Regulatory Landscape
7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
8. Influenza Vaccine – Pipeline Assessment
9. Influenza Vaccine – Clinical Trials Assessment by Phase and Trial Status
10. Key Companies Analysis

Browse all latest reports on pharmaceuticals market at

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: MarketReportsOnline
Phone: + 1 888 391 5441

Release ID: 210000